Menstruation and Anemia Research: A Community Health Study

ConditionAnemia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age21-55
SponsorUniversity of Michigan

About this trial

This research is studying if a community-based, community health worker (CHW) led psychosocial intervention improves hemoglobin levels among Black/African American and/or Hispanic or Latino women with anemia compared to standard of care.

The intervention group will demonstrate a greater mean increase in hemoglobin at follow up than the control group. The expected treatment difference effect is a between group difference of 1.0-point or greater in mean Hgb at follow up.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Self-identify as black/African American and/or Hispanic/Latino

Has had a menstrual period in the last 6 months

Hemoglobin (Hgb) by point of care (POC) test is less than 12.0 g/dL and greater than or equal to 7.0 g/dL

Able to read, write, and communicate in Spanish and/or English

Disqualifiers

Received iron infusion in the past month

Recent (within the last 4 weeks) or anticipated major surgery with anesthesia for greater than 30 minutes within the next 3 months

Undergone Bariatric (i.e. weight-loss) Surgery including Gastric Bypass Surgery, Gastric Sleeve Surgery or other Bariatric Surgery

Diagnosed with anemia related to a condition other than iron deficiency, such as thalassemia or sickle cell disease or are a carrier.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Standard of Care

    Behavioral

    Participant will be given verbal and written information on taking iron.

  • Informational Series and follow-up support

    Behavioral

    The CHW-led intervention is a structured, community-based psychosocial education series for participants randomized to the intervention arm. Trained CHWs will deliver five sessions over 10 weeks covering: (1) blood and hemoglobin basics; (2) anemia and common treatments; (3) normal menstrual health; (4) abnormal uterine bleeding (AUB), including common causes and treatments; and (5) AUB across the reproductive lifespan, with review. Sessions may be in person or use another approved, accessible modality. Standardized materials and guides will support consistency while allowing questions, discussion, and culturally responsive dialogue. CHWs will help participants understand hemoglobin results, prepare questions, connect with providers or establish care, and navigate anemia-related follow-up. CHWs will not give medical advice, diagnose conditions, or prescribe treatment.

Treatment groups

180 Participants
are divided into 2 treatment groups
Group A: Group 1-Standard of Care (SOC)Other 1 intervention
Group B: Group 2-SOC and Education/CHW inputOther 2 interventions

Trial outcomes

Primary outcomes

1

Hemoglobin levels (group level change)

Blood samples will be obtained to measure hemoglobin levels

Time frame
Visit 1 (approximately day 1), Visit 7 (approximately day 112)

Secondary outcomes

1

Hemoglobin (Hgb) values (individual change)

Blood samples will be obtained to measure hemoglobin levels

Time frame
Visit 1 (approximately day 1), Visit 7 (approximately day 112)
2

Self-reported hemoglobin levels

Self reported hemoglobin value

Time frame
Visit 1 (approximately day 1), Visit 7 (approximately day 112)
3

Anemia status awareness

Number of participants who answered correctly, "Is your hemoglobin value normal (i.e. not anemic)?

Time frame
Visit 1 (approximately day 1), Visit 7 (approximately day 112)
4

Knowledge of anemia

Anemia knowledge is measured using a 20-item anemia knowledge assessment. Scores range from 0-20 and higher scores indicate greater anemia knowledge.

Time frame
Visit 1 (approximately day 1), Visit 7 (approximately day 112)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Michigan

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

This trial is not recruiting at the moment. You can still explore other options: